Drug Farm’s DF-003 gets FDA rare pediatric disease designation for ROSAH Syndrome

Drug Farm, a clinical-stage biopharmaceutical company, has announced that its alpha-kinase 1 (ALPK1) inhibitor, DF-003, has been granted Rare Pediatric Disease (RPD) Designation by the ... Read More